Loading...








Recently Launched!
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Note: Free to use

Analysis of [MRK] Merck & Co., Inc.

Data updated 2024-Nov-22 (Friday)
 


Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab 

Note: Detail for Merck & Co., Inc. as of 2024-Nov-22 Market Close includes Performance (day & prior periods), Technical Indicators and Benchmarks. Use Related Links to view other info such as Seasonality, Correlations, Financials and Recent news for [NYSE:MRK]

Share       
Other Dates:  
Time machine widget shows Historical Detail for Merck & Co., Inc. on other dates (from 1998-Jan-02)
2024-Nov-22 Friday
 Open $100.33   High $101.79 +1.46%
 Close $99.18   Low $98.93 -1.40%
Volume 13.6 Million 1.10x Volatility 2.89%
Change $-0.68 -0.68%
Streak ↓ 1 days -0.68%

 20d SMA $100.37 -1.2%  50d SMA $107.10 -7.4%  100d SMA $113.02 -12.2%  200d SMA $120.33 -17.6%
 RSI 39  MACD 0.29  ADX 40.9  Stochastic Oscillator 48.7 37.6
 CCI -13.8  ATR 2.27  OBV 865 Million  Chaikin A/D 648 Million
 
 Market Cap 321 B  PEG Ratio 0.1  Trailing P/E 905  Forward P/E 14.9
 Price/Sales (ttm) 5.37  Price/Book (mrq) 8.54  EV/Revenue (ttm) 5.81  EV/EBITDA (ttm) 50.5
 
 % Held by Insiders 0.07%  % Held by Institutions 78.58%  Shares Short 19.6 M  Shares Short (prior month) 16.6 M
 Short Ratio 1.77  Short % of Outstanding 0.77%  Short % of Float 0.77%  Shares Short Change (mom) +18.0%
 
 Revenue/Share (ttm) $23.69  Profit Margin (ttm) 0.61%  Operating Margin (ttm) 0.08%  EBITDA (ttm) 8.3 B
 Diluted EPS (ttm) $0.14  Current Ratio (mrq) 1.25  Return on Assets (ttm) 2.64%  Return on Equity (ttm) 0.90%
 Qtr Earnings Growth (yoy)  Qtr Revenue Growth (yoy) 5.80%  Operating Cash Flow (ttm) 13 B  Free Cash Flow (ttm) 2.13 B
 
Health Care Pharmaceuticals
Alerts:

Anomalies  AI

Anomaly Detection for Merck & Co., Inc. looks at key performance metrics relative to it's history (upto 10 years) for Merck & Co., Inc. to identify unusual levels for 2024-Nov-22:

  • 20-d Consistency at 35% is extremely low. Subsequent performance over next 20 days in such cases averages +1.8% and is up 71% of the time. Subsequent performance over next 200 days in such cases averages +11.7% and is up 76% of the time
  • 100-d Performance at -21.2% is extraordinarily low. Subsequent performance over next 10 days in such cases averages +11.8% and is up 100% of the time. Subsequent performance over next 50 days in such cases averages +15.8% and is up 100% of the time
  • Intraday Swing at 2.9% is unusually high. Subsequent performance over next 200 days in such cases averages +9.9% and is up 73% of the time
  • 30-d Upswing at -11.1% is extremely low. Subsequent performance over next 20 days in such cases averages +1.6% and is up 69% of the time. Subsequent performance over next 200 days in such cases averages +10.8% and is up 84% of the time
  • 50-d Consistency at 32% is extraordinarily low. Subsequent performance over next 5 days in such cases averages -2.3% and is down 100% of the time. Subsequent performance over next 50 days in such cases averages +7.7% and is up 100% of the time
    • ...
    Sign Up or Login to see more performance anomalies

    Anomaly Detection for Merck & Co., Inc. looks at key technical metrics relative to it's history (upto 10 years) for Merck & Co., Inc. to identify unusual levels for 2024-Nov-22:

  • % off 200d SMA at -17.6% is extremely depressed. Subsequent performance over next 10 days in such cases averages +7.8% and is up 100% of the time. Subsequent performance over next 50 days in such cases averages +12.1% and is up 100% of the time
  • % off 30d EMA at -3.2% is extraordinarily depressed. Subsequent performance over next 20 days in such cases averages +2.4% and is up 72% of the time. Subsequent performance over next 50 days in such cases averages +5.3% and is up 77% of the time
  • % off 100d SMA at -12.2% is extraordinarily depressed. Subsequent performance over next 20 days in such cases averages +2.7% and is up 72% of the time. Subsequent performance over next 200 days in such cases averages +20.8% and is up 100% of the time
  • % off 50d SMA at -7.4% is extraordinarily depressed. Subsequent performance over next 20 days in such cases averages +2.7% and is up 75% of the time. Subsequent performance over next 200 days in such cases averages +13.3% and is up 89% of the time
  • MACD at -2.6 is extremely depressed. Subsequent performance over next 20 days in such cases averages +4.3% and is up 71% of the time. Subsequent performance over next 200 days in such cases averages +16.6% and is up 96% of the time
    • ...
    Sign Up or Login to see more performance anomalies

     Anomaly Details
    Anomaly Detection uses Artificial Intelligence to find abnormal levels/metrics. Subsequent performance is aggregated for similar previous occurences in history and is called out if meaningful

    Choose view type

    Daily Performance for Merck & Co., Inc.. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)



    Note: Performance over Key Timeperiods for Merck & Co., Inc. up to close of 2024-Nov-22 at $99.18
    Period Frequency Performance % off High % off Low Volatility % off SMA % off EMA Relative Volume
    01 Trailing 5-days
    60% ↑40% ↓  
    +2.98%  
    -2.6%  
    +4.1%  
    6.9%  
    +1.3%  
    +0.7%  
    1.10x  
    02 Trailing 10-days
    30% ↑70% ↓  
    -3.63%  
    -4.1%  
    +5.0%  
    9.4%  
    +1.0%  
    +0.3%  
    1.11x  
    03 Trailing 20-days
    35% ↑65% ↓  
    -4.62%  
    -5.6%  
    +5.0%  
    11.3%  
    -1.2%  
    -1.4%  
    1.10x  
    04 Trailing 30-days
    30% ↑70% ↓  
    -9.61%  
    -11.1%  
    +5.0%  
    18.1%  
    -3.6%  
    -3.2%  
    1.04x  
    05 Trailing 50-days
    32% ↑68% ↓  
    -14.40%  
    -16.9%  
    +5.0%  
    26.4%  
    -7.4%  
    -6.2%  
    1.06x  
    06 Trailing 100-days
    44% ↑56% ↓  
    -21.19%  
    -23.7%  
    +5.0%  
    37.5%  
    -12.2%  
    -10.7%  
    1.06x  
    07 Trailing 200-days
    46% ↑54% ↓  
    -21.67%  
    -26.3%  
    +5.0%  
    42.5%  
    -17.6%  
    -13.4%  
    1.01x  
    08 Month-to-date
    31% ↑69% ↓  
    -3.07%  
    -4.1%  
    +5.0%  
    9.4%  
    09 Quarter-to-date
    31% ↑69% ↓  
    -12.66%  
    -13.6%  
    +5.0%  
    21.5%  
    10 Year-to-date
    49% ↑51% ↓  
    -9.03%  
    -26.3%  
    +5.0%  
    42.5%  
    11 Trailing 52-weeks
    50% ↑50% ↓  
    -2.46%  
    -26.3%  
    +5.0%  
    42.5%  
    1-month Performance Benchmarks for Merck & Co., Inc.:


     Stock/Index/ETF:    vs.    vs.     vs.     vs.    
    Compare Performance for Merck & Co., Inc. with other stocks/etfs/crypto in a side-by-side presentation using this widget

    Related to Merck & Co., Inc.

    Information for Merck & Co., Inc.
      : Recent daily/monthly performance & benchmark comparison Currently Viewing
      : Historical performance & related information using Time Machine
      : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
      : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
      : Investigate unusual recent performance & technicals with historical context using AI
      : Seasonal performance by calendar months
      : History of Dividend Yield
      : Popular Technical indicator trends (RSI, MACD etc.)
      : Contextualizing recent performance & technical levels into historical decile buckets
      : Dollar Cost Average (DCA) over time in your portfolio
      : Key Simple & Exponential Moving Averages
      : Insights from closest historical matches to recent performance using Artificial Intelligence
      : Insights from similar historical charts to recent chart using Artificial Intelligence
      News Stories : News stories on 2024-Nov-22 on Google
      SEC Reports : Quarterly reports around 2024-Nov-22 on SEC Edgar

    Compare Merck & Co., Inc. with other assets
      : Recent performance across covered assets
      : Prior & Subsequent performance across assets on a historical date
      : Technical indicator levels across covered assets
      : Seasonal performance by calendar months across covered assets
      : Performance Correlations with other assets
      : Volatility relative to the broad market
      : Visually compare/benchmark performance with other assets over time
      : Contrast with other assets over time in a side-by-side presentation
      : Health Care sector performance which includes Merck & Co., Inc.
      : Pharmaceuticals industry performance which includes Merck & Co., Inc.
    Analyze Merck & Co., Inc. in multiple dimensions using above resources. Other comparable assets include other stocks/etfs/crypto etc.










    Ask brAIn  Experimental
    •  Hi! Ask me something. Use names or tickers to identify stock / etf / crypto symbols (e.g. aapl for Apple Inc.) . Click on below for examples of queries, list of special shortcuts & more